The BIRL’s primary goal is to identify modulators of cellular growth and metabolism. Means of inhibiting or increasing the growth of highly proliferative cells have many applications, from bioproduction to therapeutic research aimed at fighting cancer and parasitic diseases. The creation of qualitative and quantitative models of metabolism furthers therapeutic research into the mechanisms of action behind certain anticancer treatments and leads to the discovery of ways to enhance the production of secondary metabolites with high added value, like biofuels.
BIRL research relies on
The aim in developing these in silico platforms is to have industrial expertise inform the development of high-tech tools for academic research, and vice versa. In concrete terms, our work leads to the discovery of new medicines (e.g., antimalarials and anticancer drugs) and the development of organisms that can be used in the most promising fields of application for biotechnology (e.g., fermentation and biofuels).
Each year, several Sup’Biotech student interns participate in BIRL projects. This contributes valuably to their education and also benefits the laboratory, which is eager to welcome students interested in bioinformatics.
Dr. Jean-Yves TROSSET
Dr. Alexandre ISMAIL
Dr. Ouerdia ARKOUN
Privately Endowed Graduate Educational Institution - Education Authority of Créteil Registration - This school is a member of IONIS Education Group such as :